Karyopharm Therapeutics (FRA:25K) Days Payable : 242.17 (As of Jun. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Karyopharm Therapeutics Days Payable?

Karyopharm Therapeutics's average Accounts Payable for the three months ended in Jun. 2024 was €3.6 Mil. Karyopharm Therapeutics's Cost of Goods Sold for the three months ended in Jun. 2024 was €1.4 Mil. Hence, Karyopharm Therapeutics's Days Payable for the three months ended in Jun. 2024 was 242.17.

The historical rank and industry rank for Karyopharm Therapeutics's Days Payable or its related term are showing as below:

FRA:25K' s Days Payable Range Over the Past 10 Years
Min: 153.2 Med: 324.71 Max: 403.14
Current: 179.28

During the past 13 years, Karyopharm Therapeutics's highest Days Payable was 403.14. The lowest was 153.20. And the median was 324.71.

FRA:25K's Days Payable is ranked better than
56.73% of 721 companies
in the Biotechnology industry
Industry Median: 135.97 vs FRA:25K: 179.28

Karyopharm Therapeutics's Days Payable declined from Jun. 2023 (437.16) to Jun. 2024 (242.17). It may suggest that Karyopharm Therapeutics accelerated paying its suppliers.

Karyopharm Therapeutics Days Payable Historical Data

The historical data trend for Karyopharm Therapeutics's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Karyopharm Therapeutics Days Payable Chart

Karyopharm Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

395.40

372.96

307.72

149.72

220.76

Karyopharm Therapeutics Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Days Payable	Get a 7-Day Free Trial															437.16	160.20	125.46	194.39	242.17

Competitive Comparison of Karyopharm Therapeutics's Days Payable

For the Biotechnology subindustry, Karyopharm Therapeutics's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Karyopharm Therapeutics's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Karyopharm Therapeutics's Days Payable distribution charts can be found below:

* The bar in red indicates where Karyopharm Therapeutics's Days Payable falls into.

Karyopharm Therapeutics Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Karyopharm Therapeutics's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (2.618	+	2.864)	/	2 )	/	4.532	*	365
=	2.741					/	4.532	*	365
=	220.76

Karyopharm Therapeutics's Days Payable for the quarter that ended in Jun. 2024 is calculated as:

	Days Payable (Q: Jun. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Mar. 2024 )	+	Accounts Payable (Q: Jun. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Jun. 2024 )	*	Days in Period
=	( (4.626	+	2.598)	/	2 )	/	1.361	*	365 / 4
=	3.612					/	1.361	*	365 / 4
=	242.17

Karyopharm Therapeutics Days Payable Related Terms

Thank you for viewing the detailed overview of Karyopharm Therapeutics's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Karyopharm Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Karyopharm Therapeutics Inc (FRA:25K) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

KPTI:USA

Address

85 Wells Avenue, 2nd Floor, Newton, MA, USA, 02459

Website

https://www.karyopharm.com

Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company pioneering novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. XPOVIO (selinexor), is approved in the U.S. in multiple hematologic malignancy indications, including in combination with Velcade (bortezomib) and dexamethasone for the treatment of adult patients with multiple myeloma after at least one prior therapy, in combination with dexamethasone for the treatment of adult patients with heavily pretreated multiple myeloma and as a monotherapy for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma.

Karyopharm Therapeutics Headlines

No Headlines